Background: Prediabetes is a high-risk state for the future development of type 2 diabetes, which may be prevented through physical activity (PA), adherence to a healthy diet, and weight loss. Mobile health (mHealth) technology is a practical and cost-effective method of delivering diabetes prevention programs in a real-world setting.
Sweetch is an Artificial Intelligence-based platform aimed at reducing the risk and improving the outcomes of Metabolic Syndrome diseases – Diabetes, Pre-Diabetes, Hypertension, Pre-Hypertension, Obesity, and Hyperlipidemia. Below is our interview with Dana Chanan CEO at Sweetch: […]
There are currently almost 90 million pre-diabetic patients, in the United States and more than 60 million in Europe. Without intervention, every year one out of every ten patients will become diabetic. However, only 150 minutes of physical activity per week and 5-7% of weight reduction could suffice to lower the risk of becoming diabetic […]
As patient expectations concerning the quality, transparency and availability of healthcare services are setting a higher bar every day, patient-centered digital-health solutions are a vital component in the evolution of healthcare delivery. These are able to empower people to play an active role in managing their own healthcare, improve clinical outcomes, reduce costs, enhance patient-physician […]
Sweetch, an Israeli digital health startup, is on a mission to make the world a healthier place. Its first undertaking: to prevent people who are at risk for diabetes from developing the disease. More than 86 million US and 63 million European adults have a blood-sugar level that is higher than normal but not yet […]
Sweetch, an Israeli digital health startup, is on a mission to make the world a healthier place. Its first undertaking: to prevent people who are at risk for diabetes from developing the disease.
With tech giant Philips and hybrid venture capitalist group OurCrowd leading the way, another Jerusalem health startup is celebrating a multimillion dollar Series A right now. Sweetch announced on Thursday that it had raised $3.5 million for its diabetes prediction platform. The round also included Pontifax LP and Lionbird LP.
Israeli digital health startup Sweetch Health, which has developed a “digital vaccine” for diabetes, has raised $3.5 million in a Series A round led by OurCrowd, a leading equity crowdfunding platform, and Philips, a leading health technology company. Participation from prior investors also included Pontifax L.P. and Lionbird L.P. Sweetch Health has developed a revolutionary […]
In the latest startup to join the war against diabetes, Sweetch has raised $3.5 million in a Series A round led by equity crowdfunding platform OurCrowd and Philips, according to the website, NoCamels. The company is focused not on people who have been diagnosed with the chronic condition, but for those who are at risk […]
Jerusalem health startup Sweetch raised $3.5 million for its diabetes prediction platform. OurCrowd led the round, also participated Pontifax LP and Lionbird LP. Sweetch is led by CEO Dana Chanan, CTO Dan Lichtenfeld and Chief Medical Officer Yossi Bahagon, MD. They aim to use the funds to complete a pilot program and begin clinical trials.